All Stories

  1. Fukushima study for Engaging people with type 2 Diabetes in Behaviour Associated Change (FEEDBACK): study protocol for a cluster randomised controlled trial
  2. Impact of Consumer Awareness and Behavior on Business Exits in the Hospitality, Tourism, Entertainment, and Culture Industries under the COVID-19 Pandemic
  3. Regulations and the Status of Social Implementation of Services on mHealth in Japan
  4. Are We Pretender of Digitalization?—Towards a New Management Using Telework and Digital Transformation
  5. Impact of Consumer Awareness and Behavior on Business Exit in Hospitality, Tourism, Entertainment, and Culture Industries Under the Covid-19 Pandemic
  6. Superiority of Mild Interventions against COVID-19 on Public Health and Economic Measures
  7. Who explores further? Evidence on R&D outsourcing from the survey of research and development
  8. Effectiveness of Social Measures against COVID-19 Outbreaks in Selected Japanese Regions Analyzed by System Dynamic Modeling
  9. Effectiveness of Social Measures Against COVID-19 Outbreaks in Japanese Several Regions Analyzed by System Dynamic Modeling
  10. Compactin
  11. Nivolumab (Opdivo)
  12. Pravastatin (Pravachol, Mevalotin)
  13. Donepezil (Aricept)
  14. Ofloxacin and Levofloxacin (Tarivid/Cravit)
  15. Rosuvastatin (Crestor)
  16. Tamsulosin (Harnal, Flomax, OMNIC)
  17. Tocilizumab (Actemra, RoActemra)
  18. 20 Years of Human Pluripotent Stem Cell Research: It All Started with Five Lines
  19. Industrial development, technology transfer and global competition
  20. Preparing for the Future: The OECD-Countries in Comparison
  21. Role of doctoral scientists in corporate R&D in laser diode research in Japan